These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The treatment of progressive supranuclear palsy with L-dopa. Donaldson IM Aust N Z J Med; 1973 Aug; 3(4):413-6. PubMed ID: 4519129 [No Abstract] [Full Text] [Related]
7. [Progressive supranuclear paralysis. A case with "apraxia of the eye opening" and favorable response to treatment with L-dopa]. Dehaene I; Bogaerts M Acta Neurol Belg; 1971; 71(2):141-5. PubMed ID: 5000585 [No Abstract] [Full Text] [Related]
8. L-dopa for progressive supranuclear palsy. Jenkins R Lancet; 1969 Oct; 2(7623):742. PubMed ID: 4186183 [No Abstract] [Full Text] [Related]
9. Observations on the range of efficacy of L-dopa. Klawans HL Confin Neurol; 1971; 33(3):133-45. PubMed ID: 4940610 [No Abstract] [Full Text] [Related]
10. Observations on the efficacy of L-dopa in progressive supranuclear palsy. Klawans HL; Ringel SP Eur Neurol; 1971; 5(2):115-29. PubMed ID: 5117103 [No Abstract] [Full Text] [Related]
11. [Progressive supranuclear paralysis. Critical review, with a note on verbal expression disorders and action of L-dopa]. Giménez-Roldán S; Esteban A Arch Neurobiol (Madr); 1972; 35(1):41-60. PubMed ID: 5060240 [No Abstract] [Full Text] [Related]
12. [Improvement of ophthalmoplegia by 5-hydroxytryptophan in two cases of progressive supranuclear palsy]. Yukitake M; Takashima Y; Kurohara K; Matsui M; Kuroda Y Rinsho Shinkeigaku; 1996 Jul; 36(7):906-8. PubMed ID: 8952364 [TBL] [Abstract][Full Text] [Related]
13. Progressive supranuclear palsy (the Steele-Richardson-Olszewski syndrome) clinical and electrophysiological observations in eleven cases. Mastaglia FL; Grainger K; Kee F; Sadka M; Lefroy R Proc Aust Assoc Neurol; 1973; 10(0):35-44. PubMed ID: 4792160 [No Abstract] [Full Text] [Related]
16. L-dopa and amantadine hydrochloride in extra-pyramidal disorders. Parkes JD; Knill-Jones RP; Clements PJ Postgrad Med J; 1971 Feb; 47(544):116-9. PubMed ID: 5572526 [TBL] [Abstract][Full Text] [Related]
17. Modification by L-dopa of a case of progressive supranuclear palsy. With evidence of defective cerebral dopamine metabolism. Mendell JR; Engel WK; Chase TN Lancet; 1970 Mar; 1(7647):593-4. PubMed ID: 4190545 [No Abstract] [Full Text] [Related]
18. Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. Brooks DJ; Ibanez V; Sawle GV; Quinn N; Lees AJ; Mathias CJ; Bannister R; Marsden CD; Frackowiak RS Ann Neurol; 1990 Oct; 28(4):547-55. PubMed ID: 2132742 [TBL] [Abstract][Full Text] [Related]
19. Bilateral internuclear ophthalmoplegia in progressive supranuclear palsy with an overriding oculocephalic maneuver. Flint AC; Williams O Mov Disord; 2005 Aug; 20(8):1069-71. PubMed ID: 15858806 [TBL] [Abstract][Full Text] [Related]
20. Progressive external ophthalmoplegia with Parkinsonism and Dementia. Treatment with L-dopa. Report of an autopsied case. Rajput AH; Chornell G; Rozdilsky B Can J Ophthalmol; 1972 Jul; 7(3):368-74. PubMed ID: 5056570 [No Abstract] [Full Text] [Related] [Next] [New Search]